This has been suggested to occur with exenatide and liraglutide in studies using myotubes (48); however, no effect was seen in a murine model (49) or when using a pancreatic clamp with GLP-1 infusion in patients with type 2 diabetes (50). The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.